摘要
目的:比较本中心对重点药品实行动态管控前后的临床用药管理效果。方法:以本中心2020年6-11月(动态管控前)与2020年12月-2021年5月(动态管控后)的销售药品,分别作为A组和B组;对两组药品进行ABC及改良VEN分类。对分类后的ABC类品规、VEN类品规及AN、BN、CN交叉品规进行分别统计。比较动态管控前后各类品规的品规数、累计销售额和销售额占比的变化。结果:动态管控后,A类品规的品规数、品规数占比、累积销售额均有所降低;V类品规销售额和占比升高;E、N类药品销售额和占比明显降低;AN品规的品规数、总销售额占比、N类销售额占比明显降低。结论:采用ABC-改良VEN分析法选择重点监控药品,并进行动态监控管理后,AN类品规的使用得到了较好的控制,利于提高用药合理性。
Objective:To compare the clinical medication management effect of the center before and after the dynamic control of key drugs.Methods:The drugs sold by the center from June to November 2020(before dynamic control)and from December 2020 to May 2021(after dynamic control)were selected as group A and group B.The two groups of drugs were classified by ABC and improved VEN.We made statistics on the classified ABC product specifications,VEN product specifications and AN,BN and CN cross product specifications respectively.We compared the changes in the number of specifications,cumulative sales and sales proportion of various specifications before and after dynamic control.Results:After dynamic control,the number of product specifications,the proportion of product specifications and cumulative sales of class A product specifications were reduced.The sales volume and proportion of class V products increased.The sales and proportion of E and N drugs decreased significantly.The number of product specifications,the proportion of total sales of class AN and proportion of class N sales decreased significantly.Conclusion:After selecting key monitored drugs by ABC improved VEN analysis method and carrying out dynamic monitoring management,the use of an product regulations has been well controlled,which is conducive to improving the rationality of drug use.
作者
王艳红
陈磊
石岩硕
Wang Yanhong;Chen Lei;Shi Yanshuo(Fengtai Community Health Service Center of Fengtai District,Beijing City,Beijing 100071;Jimenli Community Health Service Center of Haidian District,Beijing City,Beijing 100191)
出处
《中国社区医师》
2021年第35期176-177,共2页
Chinese Community Doctors
